Acute renal failure resulting from intravenous immunoglobulin therapy.

dc.contributor.authorWajanaponsan, Non
dc.contributor.authorCheng, Shiuh-Feng
dc.date.accessioned2016-10-25T22:47:20Z
dc.date.available2016-10-25T22:47:20Z
dc.date.issued2004-09
dc.description.abstractIntravenous administration of immunoglobulin is used for the treatment of many conditions, including primary immunodeficiency states, autoimmune disorders, glomerulonephritides and polyneuropathy. Acute renal failure induced by intravenous immunoglobulin is a known but rare adverse reaction. We have a patient who was treated with IVIG for inflammatory polyneuropathy. Intravenous immunoglobulin therapy 0.5 g/kg/ d was given for 4 days. Three days after completion of IVIG therapy, patient developed decreased urine output. His serum creatinine increased from baseline of 1.3 to 7 mg/dL. Even though IVIG was discontinued, patient required hemodialysis. This case illustrated that IVIG can cause acute oliguric renal failure which is reversible after withdrawal of the drug. Risk factors include pretreatment renal impairment, diabetes mellitus, high concentration of sucrose or glucose in IVIG preparation and older age. Awareness of this serious side effects and recognition of predisposing factors provide means of avoiding a known life threatening complication of IVIG therapy.
dc.identifier.issn0017-8594
dc.identifier.pubmed15540524
dc.identifier.urihttp://hdl.handle.net/10524/53524
dc.language.isoeng
dc.subject.meshAcute Kidney Injury/chemically induced
dc.subject.meshAged
dc.subject.meshDiabetes Mellitus, Type 2/complications
dc.subject.meshExcipients/adverse effects
dc.subject.meshGuillain-Barre Syndrome/drug therapy
dc.subject.meshHumans
dc.subject.meshImmunoglobulins/administration & dosage/adverse effects
dc.subject.meshInfusions, Intravenous/adverse effects
dc.subject.meshMale
dc.subject.meshNephrosis/chemically induced
dc.subject.meshRisk Factors
dc.subject.meshSucrose/adverse effects
dc.titleAcute renal failure resulting from intravenous immunoglobulin therapy.
dc.typeArticle
dc.type.dcmiText
prism.number9
prism.pagerange266-7
prism.publicationnameHawaii Medical Journal
prism.volume63

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2004-09p266-267.pdf
Size:
223.01 KB
Format:
Adobe Portable Document Format